The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin (Q44026602)

29 November 2017

title

The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin (English)

1 reference

29 November 2017

1 reference

1 reference

1 reference

Tong PC

1

1 reference

29 November 2017

Chow CC

series ordinal

2

1 reference

29 November 2017

Jorgensen LN

series ordinal

3

1 reference

29 November 2017

Cockram CS

series ordinal

4

1 reference

29 November 2017

publication date

1 August 2002

1 reference

Diabetes Research and Clinical Practice

29 November 2017

published in

1 reference

29 November 2017

volume

57

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

93-98

1 reference

Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM).

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Combination therapy in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

Combination therapies with insulin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900022-0

7 January 2021

10.1016/S0168-8227(02)00022-0

Identifiers

DOI

1 reference

29 November 2017

1 reference